6 months | 1 year | 2 years | 5 years | |
---|---|---|---|---|
Variable | Odds ratio (95% CI) | Odds ratio (95% CI) | Odds ratio (95% CI) | Odds ratio (95% CI) |
Female sex | 0.94 (0.51–1.73) | 0.93 (0.49–1.75) | 2.48 (1.24 –5.0) | 1.24 (0.62–2.47) |
RF seropositivity | 1.54 (0.86–2.74) | 1.03 (0.57–1.87) | 1.35 (0.75–2.45) | 0.88 (0.46–1.67) |
Anti-CCP seropositivity | 1.20 (0.65–2.19) | 1.63 (0.87–3.07) | 1.09 (0.59–2.03) | 0.77 (0.39–1.49) |
Erosion | 0.53 (0.22–1.24) | 0.55 (0.23–1.34) | 0.41 (0.16–1.06) | 0.62 (0.26–1.49) |
Age | 0.86 (0.65–1.14) | 0.82 (0.61–1.08) | 0.71 (0.54–0.95) | 1.09 (0.80–1.49) |
Symptom duration | 1.11 (0.83–1.47) | 1.22 (0.91–1.64) | 1.03 (0.77–1.37) | 1.28 (0.93–1.76) |
Body Mass Index | 1.17 (0.85–1.62) | 1.04 (0.74–1.45) | 0.98 (0.70–1.38) | 0.95 (0.64–1.40) |
Current smoking | 1.24 (0.62–2.46) | 1.53 (0.76–3.08) | 0.72 (0.34–1.52) | 1.39 (0.64–3.02) |
Grip force | 0.83 (0.61–1.14) | 0.73 (0.52–1.04) | 0.71 (0.51–0.99) | 0.90 (0.65–1.24) |
VAS pain | 1.50 (1.12–1.99) | 1.69 (1.25–2.30) | 1.55 (1.15–2.09) | 1.40 (1.02–1.91) |
DAS28 | 1.44 (1.08–1.93) | 1.26 (0.94–1.69) | 1.25 (0.94–1.67) | 1.03 (0.76–1.41) |
SJC28 | 1.05 (0.80–1.38) | 0.83 (0.62–1.12) | 0.94 (0.71–1.25) | 0.71 (0.51–0.99) |
TJC28 | 1.24 (0.94–1.62) | 1.20 (0.91–1.59) | 1.11 (0.85–1.46) | 0.98 (0.71–1.35) |
HAQ | 1.31 (0.99–1.74) | 1.46 (1.10–1.95) | 1.57 (1.18–2.11) | 1.01 (0.74–1.37) |
CRP < 9 mg/l | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
CRP 9–27.4 mg/l | 0.77 (0.39–1.51) | 1.09 (0.55–2.17) | 0.64 (0.31–1.31) | 1.16 (0.57–2.38) |
CRP 27.5–174 mg/l | 0.82 (0.41–1.63) | 0.79 (0.38–1.64) | 0.96 (0.48–1.94) | 0.60 (0.27–1.36) |
ESR (mm/h) | 1.17 (0.89–1.54) | 0.99 (0.74–1.32) | 1.14 (0.86–1.51) | 0.79 (0.57–1.09) |
VAS PGA | 1.59 (1.19–2.12) | 1.44 (1.07–1.94) | 1.52 (1.13–2.05) | 1.60 (1.16–2.21) |